NO991890D0 - MÕls°kende diagnostiske og/eller terapeutiske aktive midler - Google Patents

MÕls°kende diagnostiske og/eller terapeutiske aktive midler

Info

Publication number: NO991890D0
Authority: NO; Norway
Prior art keywords: therapeutically active; active agents; measuring diagnostic; diagnostic; gas
Prior art date: 1996-10-28

Application number

NO991890A

Other languages

English (en)

Other versions

NO991890L (no

Inventor

Jo Klaveness

Pol Rongved

Gset Anders H

Helge Tolleshaug

Alan Cuthbertson

Aslak Godal

Lars Hoff

Geir Gogstad

Klaus Bryn

Vestad Anne N

Vhaug Dagfinn L

Halldis Hellebust

Magne Solbakken

Original Assignee

Nycomed Imaging As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-28

Filing date

1999-04-21

Publication date

1999-04-21

1996-10-28 Priority claimed from GBGB9622366.4A external-priority patent/GB9622366D0/en

1996-10-28 Priority claimed from GBGB9622369.8A external-priority patent/GB9622369D0/en

1997-02-04 Priority claimed from GBGB9702195.0A external-priority patent/GB9702195D0/en

1997-04-24 Priority claimed from GBGB9708265.5A external-priority patent/GB9708265D0/en

1997-06-06 Priority claimed from GBGB9711837.6A external-priority patent/GB9711837D0/en

1997-06-06 Priority claimed from GBGB9711839.2A external-priority patent/GB9711839D0/en

1999-04-21 Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As

1999-04-21 Publication of NO991890D0 publication Critical patent/NO991890D0/no

1999-06-28 Publication of NO991890L publication Critical patent/NO991890L/no

Links

239000013543 active substance Substances 0.000 title abstract 2
239000008365 aqueous carrier Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000002961 echo contrast media Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Nanotechnology (AREA)
Botany (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)

NO991890A 1996-10-28 1999-04-21 MÕls°kende diagnostiske og/eller terapeutiske aktive midler NO991890L (no)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
GBGB9622366.4A GB9622366D0 (en)	1996-10-28	1996-10-28	Improvements in or relating to diagnostic/therapeutic agents
GBGB9622369.8A GB9622369D0 (en)	1996-10-28	1996-10-28	Improvements in or relating to diagnostic/therapeutic agents
GBGB9702195.0A GB9702195D0 (en)	1997-02-04	1997-02-04	Improvements in or relating to diagnostic/therapeutic agents
GBGB9708265.5A GB9708265D0 (en)	1997-04-24	1997-04-24	Contrast agents
US4926497P	1997-06-06	1997-06-06
US4926697P	1997-06-06	1997-06-06
US4926397P	1997-06-06	1997-06-06
GBGB9711837.6A GB9711837D0 (en)	1997-06-06	1997-06-06	Improvements in or relating to diagnostic / therapeutic agents
GBGB9711839.2A GB9711839D0 (en)	1997-06-06	1997-06-06	Improvements in or relating to diagnostic/therapeutic agents
PCT/GB1997/002953 WO1998018500A2 (en)	1996-10-28	1997-10-28	Improvements in or relating to diagnostic/therapeutic agents

Publications (2)

Publication Number	Publication Date
NO991890D0 true NO991890D0 (no)	1999-04-21
NO991890L NO991890L (no)	1999-06-28

Family

ID=27576371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991890A NO991890L (no)	1996-10-28	1999-04-21	MÕls°kende diagnostiske og/eller terapeutiske aktive midler

Country Status (15)

Country	Link
EP (1)	EP1007101B1 (no)
JP (1)	JP2001511765A (no)
KR (1)	KR20000052830A (no)
CN (1)	CN1238700A (no)
AT (1)	ATE326242T1 (no)
AU (1)	AU733477B2 (no)
BG (1)	BG103439A (no)
BR (1)	BR9713978A (no)
CA (1)	CA2269985A1 (no)
DE (1)	DE69735901T2 (no)
HU (1)	HUP0000357A2 (no)
IL (1)	IL129445A0 (no)
NO (1)	NO991890L (no)
NZ (1)	NZ335799A (no)
WO (1)	WO1998018500A2 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2250401A1 (en)	1996-03-29	1997-10-09	Thomas Budinger	Enhancement of nmr and mri in the presence of hyperpolarized noble gases
US5846517A (en) *	1996-09-11	1998-12-08	Imarx Pharmaceutical Corp.	Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US20010003580A1 (en)	1998-01-14	2001-06-14	Poh K. Hui	Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
JP2002512886A (ja) *	1998-04-28	2002-05-08	ニユコメド・イメージング・アクシエセルカペト	分離方法におけるまたはこれに関する改良
GB9917111D0 (en)	1999-07-21	1999-09-22	Nycomed Imaging As	Method
US8263739B2 (en)	2000-06-02	2012-09-11	Bracco Suisse Sa	Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP2279757A3 (en) *	2000-06-02	2011-08-03	Bracco Suisse SA	Compounds for targeting endothelial cells
US6652833B2 (en) *	2000-07-13	2003-11-25	The Regents Of The University Of California	Functionalized active-nucleus complex sensor
US7061237B2 (en)	2000-07-13	2006-06-13	The Regents Of The University Of California	Remote NMR/MRI detection of laser polarized gases
CN1243759C (zh)	2001-03-02	2006-03-01	日本油脂株式会社	聚亚烷基氧改性的磷脂及其制备方法
US7794693B2 (en)	2002-03-01	2010-09-14	Bracco International B.V.	Targeting vector-phospholipid conjugates
US7211240B2 (en)	2002-03-01	2007-05-01	Bracco International B.V.	Multivalent constructs for therapeutic and diagnostic applications
WO2004065621A1 (en)	2002-03-01	2004-08-05	Dyax Corp.	Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7666979B2 (en)	2002-03-01	2010-02-23	Bracco International B.V.	Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
US7261876B2 (en)	2002-03-01	2007-08-28	Bracco International Bv	Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en)	2002-03-01	2014-01-07	Bracco Suisse Sa	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7432331B2 (en)	2002-12-31	2008-10-07	Nektar Therapeutics Al, Corporation	Hydrolytically stable maleimide-terminated polymers
EP1578842B1 (en)	2002-12-31	2009-10-07	Nektar Therapeutics Al, Corporation	Hydrolytically stable maleimide-terminated polymers
DE602004029010D1 (de)	2003-02-04	2010-10-21	Bracco Suisse Sa	Ultraschall kontrastmittel und verfahren zur erstellung
US9750821B2 (en)	2003-12-22	2017-09-05	Bracco Suisse S.A.	Gas-filled microvesicle assembly for contrast imaging
AU2004308757B2 (en) *	2003-12-22	2010-06-17	Bracco Suisse S.A.	Assembly of gas-filled microvesicle with active component for contrast imaging
WO2005084715A2 (en)	2004-03-04	2005-09-15	Ge Healthcare As	Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
EP1784228B1 (en)	2004-08-18	2016-10-05	Bracco Suisse SA	Gas-filled microvesicles composition for contrast imaging
US8182790B2 (en)	2004-11-22	2012-05-22	Ge Healthcare As	Contrast agents
JP2006182673A (ja) *	2004-12-27	2006-07-13	Kenji Yamamoto	マーカー付き医薬
EP2091570A1 (en) *	2006-12-20	2009-08-26	GE Healthcare AS	Contrast agents
CN101773675B (zh) *	2010-03-05	2012-05-30	中山大学	一种负载液态氟碳的聚合物纳米超声显像囊泡及其制备方法
US20130072854A1 (en) *	2011-09-19	2013-03-21	General Electric Company	Microbubble complexes and methods of use
WO2014117232A1 (pt) *	2013-02-04	2014-08-07	Farret Neto Abdo	Preparação medicinal sob a forma de espuma para a liberação prolongada de medicamentos e sistema para obtenção da preparação medicinal
JP6637484B2 (ja) *	2014-08-07	2020-01-29	ザジェネラルホスピタルコーポレイション	血小板を標的とするマイクロ流体細胞単離
BR112017013787A2 (pt)	2014-12-31	2018-03-13	Lantheus Medical Imaging, Inc.	Composições de microesfera de gás lipídio- encapsulado e métodos relacionados
CA3022698A1 (en)	2016-05-04	2017-11-09	Lantheus Medical Imaging, Inc.	Methods and devices for preparation of ultrasound contrast agents
US9789210B1 (en)	2016-07-06	2017-10-17	Lantheus Medical Imaging, Inc.	Methods for making ultrasound contrast agents
CN116223678A (zh) *	2023-03-09	2023-06-06	石家庄四药有限公司	一种测定血液中依托咪酯的方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN172208B (no) *	1990-04-02	1993-05-01	Sint Sa
US5780010A (en) *	1995-06-08	1998-07-14	Barnes-Jewish Hospital	Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US5849727A (en) *	1996-06-28	1998-12-15	Board Of Regents Of The University Of Nebraska	Compositions and methods for altering the biodistribution of biological agents

1997
- 1997-10-28 JP JP52018698A patent/JP2001511765A/ja not_active Ceased
- 1997-10-28 CA CA002269985A patent/CA2269985A1/en not_active Abandoned
- 1997-10-28 WO PCT/GB1997/002953 patent/WO1998018500A2/en active IP Right Grant
- 1997-10-28 AU AU47182/97A patent/AU733477B2/en not_active Ceased
- 1997-10-28 BR BR9713978-5A patent/BR9713978A/pt unknown
- 1997-10-28 NZ NZ335799A patent/NZ335799A/xx unknown
- 1997-10-28 AT AT97909512T patent/ATE326242T1/de not_active IP Right Cessation
- 1997-10-28 DE DE69735901T patent/DE69735901T2/de not_active Expired - Fee Related
- 1997-10-28 HU HU0000357A patent/HUP0000357A2/hu unknown
- 1997-10-28 IL IL12944597A patent/IL129445A0/xx unknown
- 1997-10-28 EP EP97909512A patent/EP1007101B1/en not_active Expired - Lifetime
- 1997-10-28 CN CN97180164A patent/CN1238700A/zh active Pending
- 1997-10-28 KR KR1019990703659A patent/KR20000052830A/ko not_active Application Discontinuation
1999
- 1999-04-21 NO NO991890A patent/NO991890L/no not_active Application Discontinuation
- 1999-05-27 BG BG103439A patent/BG103439A/xx unknown

Also Published As

Publication number	Publication date
AU733477B2 (en)	2001-05-17
NZ335799A (en)	2000-11-24
DE69735901D1 (de)	2006-06-22
ATE326242T1 (de)	2006-06-15
WO1998018500A8 (en)	1999-11-25
EP1007101A2 (en)	2000-06-14
CA2269985A1 (en)	1998-05-07
WO1998018500A2 (en)	1998-05-07
KR20000052830A (ko)	2000-08-25
AU4718297A (en)	1998-05-22
JP2001511765A (ja)	2001-08-14
CN1238700A (zh)	1999-12-15
WO1998018500A3 (en)	1998-07-23
HUP0000357A2 (hu)	2000-06-28
NO991890L (no)	1999-06-28
EP1007101B1 (en)	2006-05-17
DE69735901T2 (de)	2007-05-10
BG103439A (en)	2000-01-31
IL129445A0 (en)	2000-02-29
BR9713978A (pt)	2000-05-02

Legal Events

Date	Code	Title	Description
2003-12-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO991890D0 (no)	1999-04-21	MÕls°kende diagnostiske og/eller terapeutiske aktive midler
NO991889D0 (no)	1999-04-21	MÕls°kende diagnostiske og/eller terapeutiske aktive midler
TR200100922T2 (tr)	2001-09-21	Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
IT8021275A0 (it)	1980-04-09	Pacco elettrodico e impiego di esso.
BR8301720A (pt)	1983-12-13	Sistema de grampeamento cirurgico, instrumento de grampeamento cirurgico e cartucho
DE3677431D1 (de)	1991-03-14	Klonierung und expression von bacillus thuringiensis-toxigenen, die fuer kaefer der ordnung coleoptera toxisch sind.
ES2150563T3 (es)	2000-12-01	Sistema de electrotransporte con sistema de liberacion de medicamento mejorado.
ITTO950367A0 (it)	1995-05-10	Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
SE7714066L (sv)	1978-06-14	Tillforselenhet for biologiskt aktiva emnen
WO1998018495A3 (en)	1998-07-30	Improvements in or relating to diagnostic/therapeutic agents
ATE236595T1 (de)	2003-04-15	Selbstklebende fertigbandage zur immobilisation des handgelenks
DK0385279T3 (da)	1994-06-27	Biologisk aktive midler samt præparater og materialer, der indeholder de biologisk aktive midler
DE3671970D1 (de)	1990-07-19	Probekoerper fuer ultraschallpruefung.
ATE233483T1 (de)	2003-03-15	Wässrige lösung zum konservieren von gewebe und organen
ATE199184T1 (de)	2001-02-15	Testverfahren
NO913035L (no)	1992-02-07	(2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
NO157821C (no)	1988-05-25	Forgrenet polyamidoamin og anvendelse derav for aa oeke vaatstyrken til papir.
NO860733L (no)	1986-08-29	N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
ATE28188T1 (de)	1987-07-15	Antikonvulsive mittel.
DE68914522D1 (de)	1994-05-19	Isobenzothiazolon als chromogenische Thiol-Indikatoren und dessen Derivate.
DE68908764D1 (de)	1993-10-07	Pufferlösungssysteme und Elektrolyten zur Eichung von Analysegeräten.
TR20254A (tr)	1980-11-01	1,3,4-tiyadiyazol-2-karboksilik asit tuerevleri,bu bilesim imaline mahsus usuller ve bunlari ihtiva eden fungisit ve nemasit maddeler
DK1237537T3 (da)	2006-12-27	Præparat i form af en gel til modtagelse af et aktivt stof i oplösning eller suspension, især til anvendelse på en slimhinde, og fremgangsmåde til dets fremstilling
ATE57526T1 (de)	1990-11-15	P-acylaminobenzamide.
DE3483002D1 (de)	1990-09-20	Waesserige dispersionen von polyaminen und poly(dihydrobenzoxazinen).